Phase I Study of Surface-Controlled Water Soluble Curcumin (THERACURMIN CR-011L)

NCT01201694 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Advanced Cancers

Interventions

DRUG: Surface-Controlled Water Soluble Curcumin
DRUG: Surface-Controlled Water Soluble Curcumin MTD

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]
[object Object]